A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults
AZD5462-D9090C00012
Phase 1 other active
Quick answer
A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults for Chronic Heart Failure is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Chronic Heart Failure
- Phase
- Phase 1
- Modality
- other
- Status
- active